Cargando…

The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer

Inflammation has been reported to play an important role in cancer progression and various inflammatory markers have been reported to be useful prognostic markers. The aim of this retrospective study was to evaluate the significance of the C-reactive protein to albumin (CRP/ALB) ratio in colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibutani, Masatsune, Maeda, Kiyoshi, Nagahara, Hisashi, Iseki, Yasuhito, Hirakawa, Kosei, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069226/
https://www.ncbi.nlm.nih.gov/pubmed/27812440
http://dx.doi.org/10.1186/s40064-016-3529-y
_version_ 1782460897297432576
author Shibutani, Masatsune
Maeda, Kiyoshi
Nagahara, Hisashi
Iseki, Yasuhito
Hirakawa, Kosei
Ohira, Masaichi
author_facet Shibutani, Masatsune
Maeda, Kiyoshi
Nagahara, Hisashi
Iseki, Yasuhito
Hirakawa, Kosei
Ohira, Masaichi
author_sort Shibutani, Masatsune
collection PubMed
description Inflammation has been reported to play an important role in cancer progression and various inflammatory markers have been reported to be useful prognostic markers. The aim of this retrospective study was to evaluate the significance of the C-reactive protein to albumin (CRP/ALB) ratio in colorectal cancer patients who received palliative chemotherapy. We performed a retrospective review of 99 patients who underwent palliative chemotherapy for unresectable colorectal cancer between 2005 and 2010. The cutoff value of the CRP/ALB ratio was determined based on a receiver operating characteristics curve analysis. The relationship between the CRP/ALB ratio and survival was assessed. The cutoff value for the CRP/ALB ratio was 0.183. The high pretreatment CRP/ALB ratio group showed significantly worse overall survival. Patients with a high pretreatment CRP/ALB ratio and in whom the CRP/ALB ratio normalized after chemotherapy tended to have better overall survival than those in whom both the pretreatment and posttreatment CRP/ALB ratios were high. The CRP/ALB ratio is a useful marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer.
format Online
Article
Text
id pubmed-5069226
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-50692262016-11-03 The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer Shibutani, Masatsune Maeda, Kiyoshi Nagahara, Hisashi Iseki, Yasuhito Hirakawa, Kosei Ohira, Masaichi Springerplus Research Inflammation has been reported to play an important role in cancer progression and various inflammatory markers have been reported to be useful prognostic markers. The aim of this retrospective study was to evaluate the significance of the C-reactive protein to albumin (CRP/ALB) ratio in colorectal cancer patients who received palliative chemotherapy. We performed a retrospective review of 99 patients who underwent palliative chemotherapy for unresectable colorectal cancer between 2005 and 2010. The cutoff value of the CRP/ALB ratio was determined based on a receiver operating characteristics curve analysis. The relationship between the CRP/ALB ratio and survival was assessed. The cutoff value for the CRP/ALB ratio was 0.183. The high pretreatment CRP/ALB ratio group showed significantly worse overall survival. Patients with a high pretreatment CRP/ALB ratio and in whom the CRP/ALB ratio normalized after chemotherapy tended to have better overall survival than those in whom both the pretreatment and posttreatment CRP/ALB ratios were high. The CRP/ALB ratio is a useful marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer. Springer International Publishing 2016-10-18 /pmc/articles/PMC5069226/ /pubmed/27812440 http://dx.doi.org/10.1186/s40064-016-3529-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Shibutani, Masatsune
Maeda, Kiyoshi
Nagahara, Hisashi
Iseki, Yasuhito
Hirakawa, Kosei
Ohira, Masaichi
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
title The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
title_full The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
title_fullStr The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
title_full_unstemmed The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
title_short The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
title_sort significance of the c-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069226/
https://www.ncbi.nlm.nih.gov/pubmed/27812440
http://dx.doi.org/10.1186/s40064-016-3529-y
work_keys_str_mv AT shibutanimasatsune thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT maedakiyoshi thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT nagaharahisashi thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT isekiyasuhito thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT hirakawakosei thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT ohiramasaichi thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT shibutanimasatsune significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT maedakiyoshi significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT nagaharahisashi significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT isekiyasuhito significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT hirakawakosei significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer
AT ohiramasaichi significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer